LENZ Therapeutics, Inc.
LENZNasdaqCIK 1815776HealthcareFiscal year ends Dec 31
Reports and events: 105 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1120:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001815776-26-000052 |
| 2026-08-1120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000051 |
| 2026-07-0221:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001815776-26-000046 |
| 2026-06-1220:08 ET | 8-K | 5.07 Shareholder vote results | 0001815776-26-000041 |
| 2026-05-1120:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001815776-26-000037 |
| 2026-05-1120:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000035 |
| 2026-04-2820:39 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001815776-26-000026 |
| 2026-03-2420:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001815776-26-000011 |
| 2026-03-2412:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000008 |
| 2026-01-0722:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000003 |
| 2025-12-1221:15 ET | 8-K | 8.01 Other events | 0001815776-25-000077 |
| 2025-11-1021:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-274461 |
| 2025-11-0721:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000043 |
| 2025-11-0521:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001815776-25-000071 |
| 2025-11-0513:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000069 |
| 2025-10-0820:40 ET | 8-K | 8.01 Other events | 0001815776-25-000064 |
| 2025-09-3012:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-25-000062 |
| 2025-09-2220:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-211357 |
| 2025-08-2021:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-110483 |
| 2025-07-3120:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-25-000059 |
| 2025-07-3020:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001815776-25-000056 |
| 2025-07-3012:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000054 |
| 2025-07-1420:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-095617 |
| 2025-06-2420:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-089455 |
| 2025-06-1220:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-085511 |
| 2025-06-1020:55 ET | 8-K | 5.07 Shareholder vote results | 0001815776-25-000036 |
| 2025-05-0920:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-012499 |
| 2025-05-0720:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001815776-25-000032 |
| 2025-05-0720:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000030 |
| 2025-04-2820:30 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001193125-25-100630 |
| 2025-04-1512:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001815776-25-000025 |
| 2025-04-0420:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-016824 |
| 2025-03-1920:38 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001815776-25-000019 |
| 2025-03-1920:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000017 |
| 2024-11-0822:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-254239 |
| 2024-11-0612:35 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001815776-24-000071 |
| 2024-11-0612:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000069 |
| 2024-10-2812:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000064 |
| 2024-09-1120:09 ET | S-1 | Registration statement | 0001628280-24-040130 |
| 2024-08-1420:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001815776-24-000060 |
| 2024-08-1420:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000058 |
| 2024-08-1212:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000053 |
| 2024-07-1512:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001815776-24-000049 |
| 2024-05-0821:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001815776-24-000042 |
| 2024-05-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000039 |
| 2024-04-0922:36 ET | S-1/A | Registration statement, amended | 0001628280-24-015318 |
| 2024-04-0311:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000035 |
| 2024-03-2920:46 ET | S-1 | Registration statement | 0001628280-24-013816 |
| 2024-03-2820:16 ET | SC 13D | Ownership report, active investor | 0001104659-24-040539 |
| 2024-03-2520:43 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-076566 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.